BRIEF-Pluxee Acquires Beneficio Facil In Brazil

Protalix Biotherapeutics, Inc. -2.97%
Dow Jones Industrial Average -0.26%
S&P 500 index -0.13%
NASDAQ -0.16%

Protalix Biotherapeutics, Inc.

PLX

2.13

-2.97%

Dow Jones Industrial Average

DJI

46446.57

-0.26%

S&P 500 index

SPX

6566.76

-0.13%

NASDAQ

IXIC

21806.25

-0.16%

Nov 29 (Reuters) - Pluxee NV PLX.PA:

  • PLUXEE ACQUIRES BENEFICIO FACIL IN BRAZIL AND REINFORCES ITS EMPLOYEE MOBILITY OFFER

  • TRANSACTION ACCRETIVE TO EBITDA MARGIN FROM FIRST YEAR

  • ACQUISITION SUBJECT TO APPROVAL FROM CENTRAL BANK OF BRAZIL

  • ACQUISITION FULLY FUNDED FROM EXISTING FINANCIAL RESOURCES

  • EXPECTS SUBSTANTIAL GROWTH SYNERGIES FROM INTEGRATION

  • TRANSACTION TO HAVE MINIMAL EFFECT ON LEVERAGE

  • AGREEMENT IS SUBJECT TO APPROVAL FROM CENTRAL BANK OF BRAZIL (BACEN)

Source text: ID:nGNE6Vxsjl

Further company coverage: PLX.PA


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.